Skip to main content
. 2016 Jun 29;12(2):1415–1421. doi: 10.3892/ol.2016.4798

Table III.

Correlation between KRAS mutational status and survival.

A, KRAS mutation status in toto

Confidence interval

Parameter Odds Ratio Lower Upper P-value
TTM
  KRAS status 1.187 0.816 1.726 0.198
  Female and KRAS status 0.799 0.444 1.439 0.254
  Male and KRAS status 1.583 0.962 2.606 0.035
OS
  KRAS status 1.286 0.874 1.903 0.107
  Female and KRAS status 1.151 0.825 2.766 0.100
  Male and KRAS status 1.141 0.679 1.935 0.345

B, KRAS codon-specific mutations

Confidence interval

Parameter P-value Hazard ratio Lower Upper

TTM
  Gender 0.011 0.728 0.569 0.931
  Age at diagnosis 0.473 1.161 0.771 1.750
  Codon 12 mutations 0.907 1.037 0.559 1.924
  Codon 13 mutations 0.861 1.045 0.634 1.721
  Other codon mutations 0.806 1.076 0.598 1.935

TTM, time to first metastasis; OS, overall survival.